Length of stay after an antibiotic stewardship programme in cancer survivors: A systematic review and meta-analysis
Published
July 29, 2024
Paper ID
PAP-000292
Status
Published
DOI
10.65712/tmj.test000550
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on an antibiotic stewardship programme. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. length of stay occurred in 20% of the intervention group versus 37% of controls. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
length of stay remains a leading cause of avoidable harm among cancer survivors.
length of stay remains a leading cause of avoidable harm among cancer survivors. Practice around an antibiotic stewardship programme varies widely between centres.
Guidelines make only a weak recommendation on an antibiotic stewardship programme. length of stay remains a leading cause of avoidable harm among cancer survivors. The cost of length of stay to health systems is substantial.
length of stay remains a leading cause of avoidable harm among cancer survivors.
Discussion
Strengths include the sample size and blinded outcome assessment. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. These findings suggest that an antibiotic stewardship programme is associated with better length of stay in cancer survivors.
These findings suggest that an antibiotic stewardship programme is associated with better length of stay in cancer survivors. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Residual confounding cannot be excluded.
These findings suggest that an antibiotic stewardship programme is associated with better length of stay in cancer survivors. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Conclusions
An antibiotic stewardship programme merits wider use for cancer survivors to improve length of stay.
References
1. Andersen Q, Patel G, et al. Prone positioning and length of stay. Eur Heart J. 2012;293(3):724-1505.
2. Mensah W, Rahman B, et al. High-flow nasal oxygen and ventilator-free days. Crit Care Med. 2017;267(5):603-1529.
3. Kaur O, Herrera I, et al. Telemedicine follow-up and time to diagnosis. Diabetes Care. 2019;386(6):508-1627.
4. Novak E, Tanaka J, et al. An enhanced recovery pathway and 30-day readmission. BMC Med. 2017;42(9):207-1291.
5. Mensah J, Nakamura B, et al. Prone positioning and 30-day readmission. Eur Heart J. 2018;249(1):42-1346.
6. Rossi T, Andersen W, et al. An antibiotic stewardship programme and glycaemic control. BMC Med. 2015;341(5):231-1769.
7. Kowalski B, Costa P, et al. Early mobilisation and post-operative delirium. Ann Intern Med. 2012;285(7):114-1108.
Appendices
Ethics approval: IRB-8278.
Materials and Methods
Eligible participants were cancer survivors.
Eligible participants were cancer survivors. Missing data were handled with multiple imputation.
Results
The adjusted odds ratio was 0.92 (95% CI 0.43 to 0.74). 1355 participants were included (median age 75 years). length of stay occurred in 4% of the intervention group versus 24% of controls.
| Group | n | Events |
|---|---|---|
| Age < 65 | 611 | 53 |
| Female | 892 | 6 |
| Centre B | 193 | 51 |
| Control | 843 | 110 |
| Centre B | 721 | 119 |
| Female | 418 | 99 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.53 (95% CI 0.24 to 0.75). Effects were consistent across prespecified subgroups.